Risk factors for haemorrhage in patients with haematological malignancies

<p>Haematological malignancies and their treatment lead to prolonged periods of severe thrombocytopenia (platelet count ≤ 50 x 10<sup>9</sup>/l). Despite the use of prophylactic platelet transfusions, haemorrhage remains an important complication during this thrombocytopenic period...

Full description

Bibliographic Details
Main Author: Estcourt, LJ
Other Authors: Murphy, MF
Format: Thesis
Language:English
Published: 2014
Subjects: